Streetbeat News

Analyst Ratings

LIVN

Needham analyst Mike Matson has reiterated a Buy rating on LivaNova (NASDAQ:LIVN) and maintained a price target of $62.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 11:05 am

IONS

Needham analyst Joseph Stringer has reiterated a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) and maintained a $60 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:52 am

PLCE

Telsey Advisory Group analyst Dana Telsey has maintained a Market Perform rating on Children's Place (NASDAQ:PLCE) but has lowered the price target from $31 to $24.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:39 am

BBWI

Telsey Advisory Group analyst Dana Telsey has maintained an Outperform rating on Bath & Body Works (NYSE:BBWI) but reduced the price target from $52 to $42.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:38 am

DKS

Telsey Advisory Group analyst Joseph Feldman has reiterated an Outperform rating on Dick's Sporting Goods (NYSE:DKS) and maintained a price target of $140.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:35 am

ROST

Telsey Advisory Group analyst Dana Telsey has maintained a 'Market Perform' rating on Ross Stores (NASDAQ:ROST) and increased the price target from $130 to $135.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:33 am

BBY

Telsey Advisory Group analyst Joseph Feldman has maintained a 'Market Perform' rating on Best Buy Co (NYSE:BBY) but lowered the price target from $85 to $80.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:30 am

GPS

Telsey Advisory Group analyst Dana Telsey has maintained a 'Market Perform' rating on Gap Inc. (NYSE:GPS) and increased the price target from $11 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:23 am

M

Telsey Advisory Group analyst Dana Telsey has maintained a 'Market Perform' rating on Macy's (NYSE:M) and increased the price target from $14 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:15 am

ISRG

HSBC analyst Helen Fang has initiated coverage on Intuitive Surgical (NASDAQ:ISRG) with a Buy rating and set a price target of $318.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 10:13 am